首页> 外文期刊>Kidney International Reports >SUN-157 Combined Cell Therapy with Serelaxin Reduces Established Renal Inflammation and Fibrosis Following Obstructive Nephropathy
【24h】

SUN-157 Combined Cell Therapy with Serelaxin Reduces Established Renal Inflammation and Fibrosis Following Obstructive Nephropathy

机译:SUN-157联合细胞疗法与Serelaxin减少阻塞性肾病后已确立的肾脏炎症和纤维化

获取原文
       

摘要

Ferroptosis is expressed in renal fibrosis in CKD patients and in TGF-b-treated tubular epithelial cells (TECs) and the obstructive nephropathy mouse model. The intervention of ferroptosis by agonist and inhibitor has effect on the renal fibrosis in HK2 cells. These data indicates that the potential role of ferroptosisin renal fibrosis.
机译:在CKD患者以及TGF-b治疗的肾小管上皮细胞(TECs)和梗阻性肾病小鼠模型中,肾脏肥大中表达了肥大症。激动剂和抑制剂对铁的治疗对HK2细胞的肾纤维化有影响。这些数据表明铁质增生在肾纤维化中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号